Page 97 Acute Pain Management
P. 97




publications
have
reported
that
the
presence
of
an
APS
reduced
pain
scores
(Gould
et
al,
1992

Level
III‐3;
Harmer
&
Davies,
1998
Level
III‐3;
Miaskowski
et
al,
1999
Level
IV;
Sartain
&
Barry,
1999

Level
III‐3;
Salomaki
et
al,
2000
Level
III‐3;
Bardiau
et
al,
2003
Level
III‐3;
Stadler
et
al,
2004
Level
III‐3)

and
side
effects
(Schug
&
Torrie,
1993
Level
IV;
Stacey
et
al,
1997
Level
III‐3;
Miaskowski
et
al,
1999

Level
IV;
Sartain
&
Barry,
1999
Level
III‐3).


A
review
of
publications
(primarily
audits)
looking
at
the
effectiveness
of
APSs
(77%
were

physician‐based,
23%
nurse‐based)
concluded
that
the
implementation
of
an
APS
is
associated

with
a
significant
improvement
in
postoperative
pain
and
a
possible
reduction
in
PONV,
but

that
it
was
not
possible
to
determine
which
model
was
superior
(Werner
et
al,
2002
Level
IV).

The
authors
comment,
however,
that
it
is
not
possible
to
assess
the
contribution
of
factors

such
as
an
increased
awareness
of
the
importance
of
postoperative
analgesia,
the
use
of
more

effective
analgesic
regimens
(eg
epidural
analgesia),
the
effects
of
APS
visits
and
better

strategies
for
antiemetic
therapy.


Possible
benefits
of
an
APS
are
summarised
in
Table
3.1.

Although
systematic
reviews
have
been
attempted
(McDonnell
et
al,
2003;
NICS,
2002),
the
poor

quality
of
the
studies
looking
at
the
effectiveness
or
otherwise
of
APSs,
and
the
many
different

types
of
APSs,
means
that
a
proper
meta‐analysis
cannot
be
performed.


In
addition,
the
above
studies
looked
at
outcome
in
terms
of
immediate
pain
and
side
effects

in
postoperative
patients
only.
It
is
possible
that
an
APS
may
benefit
patients
in
other
ways.

 CHAPTER
3

Combination
of
an
APS
with
a
physician‐based
critical
care
outreach
team,
which

systematically
reviewed
high‐risk
postoperative
patients
for
3
days
after
their
return
to
a

general
ward,
showed
a
significant
improvement
in
postoperative
outcome;
the
incidence
of

serious
adverse
events
decreased
from
23
events
per
100
patients
to
16
events
per
100

patients,
and
the
30‐day
mortality
fell
from
9%
to
3
%
(Story
et
al,
2006
Level
III‐2).
Finally,

members
of
an
APS
may
also
be
more
likely
to
recognise
the
early
onset
of
neuropathic
pain

associated
with
surgery,
trauma
or
medical
disease,
and
institute
the
appropriate
treatment

(Counsell
et
al,
2008).

Table
3.1
 Possible
benefits
of
an
Acute
Pain
Service

Benefit

 References


Better
pain
relief
 Gould
et
al,
1992;
Harmer
&
Davies,
1998;
Miaskowski
et
al,

1999;
Sartain
&
Barry,
1999;
Salomaki
et
al,
2000;
Werner
et

al,
2002;
Bardiau
et
al,
2003;
Stadler
et
al,
2004

Lower
incidence
of
side
effects

 Schug
&
Torrie,
1993;
Stacey
et
al,
1997;
Miaskowski
et
al,

1999;
Sartain
&
Barry,
1999;
Werner
et
al,
2002

Lower
postoperative
morbidity/
mortality
 Story
et
al,
2006


Management
of
analgesic
techniques
that
 Obata
et
al,
1999;
Senturk
et
al,
2002;
Gehling
&
Tryba,
2003

may
reduce
the
incidence
of
persistent

pain
after
surgery















 Acute
pain
management:
scientific
evidence
 49

   92   93   94   95   96   97   98   99   100   101   102